Exencial Wealth Advisors, LLC Invitae Corp Transaction History

Exencial Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$14.7 - $28.67 $272,038 - $530,567	-18,506 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$24.31 - $33.6 $3,306 - $4,569	136 Added 0.74%	18,506 $526,000
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $75,556 - $116,998	2,896 Added 18.72%	18,370 $620,000
Q1 2021 May 06, 2021	BUY	$33.06 - $56.93 $267,819 - $461,189	8,101 Added 109.87%	15,474 $591,000
Q4 2020 Feb 11, 2021	BUY	$39.09 - $57.4 $17,981 - $26,404	460 Added 6.65%	7,373 $308,000

Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $196,536 - $308,803	6,913 New	6,913 $299,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.